Chicago Dental Society News
Milestone Scientific to Exhibit at the Chicago Dental Society's 143rd Midwinter Meeting
LIVINGSTON, N.J.,
WHEN: Friday, February 22, 2008 - Sunday, February 24, 2008 WHERE: Booth #2206 McCormick Place Lakeside Center 2301 South Lake Shore Drive Chicago, Illinois WHO: Key Milestone officials, along with Henry Schein representatives, will be available to discuss and demonstrate the STA(TM) System. Learn first hand: — how Milestone is redefining the standard of care for the delivery of local anesthesia in dentistry; and — how the STA System is promoting enhanced patient care and improved practice efficiency for those dentists who have adopted this novel technology since its unveiling at the 142nd Midwinter Meeting last year.
Members of the press must register at the Press Booth for this event. For details on obtaining Press Credentials, please visit: http://www.cds.org/media/. To book a one-on-one meeting or demonstration, please contact
The Midwinter Meeting is among the top three dental meetings in the U.S. and one of the top 10 conventions in
About the
The
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer 407-585-1080 or via email at mlss@efcg.net
SOURCE Milestone Scientific Inc.
Search Our News Using Google Search
Can't find what you want? Try using Google:
